Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDIV × ethyl pyruvate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Proflavine 6 pembrolizumab 2 Tacrolimus 2 Pyridostigmine Bromide 2 Prednisone 2 Microbial Collagenase 2 sargramostim 1 plerixafor 1 pegfilgrastim 1 olaparib 1 macimorelin 1 keyhole-limpet hemocyanin 1 ethyl pyruvate 1 compound W 1 blinatumomab 1 Watchful Waiting 1 Uracil 1 Tegafur 1 Surgical Procedures, Operative 1 Steroids 1 Sodium Chloride 1 Sirolimus 1 Salicylates 1 Peptides 1 PM 01183 1 Mycophenolic Acid 1 Monatide (IMS 3015) 1 Mifepristone 1 Methylprednisolone 1 Methotrexate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01712295 2012-10-23

17% Salicylate Versus 17% Salicylate-Ethyl Pyruvate for Plantar Foot Warts

Grossman, Michael, D.P.M.

Phase 4 Unknown

Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡